z-logo
open-access-imgOpen Access
MBX-102/JNJ39659100, a Novel Peroxisome Proliferator Activated Receptor-γ Ligand with Weak Transactivation Activity Retains Full Anti-Diabetic Properties in the Absence of Side Effects
Author(s) -
Francine M. Gregoire,
Fang Zhang,
Holly J. Clarke,
Thomas A. Gustafson,
Dorothy D. Sears,
Svetlana Favelyukis,
James M. Lenhard,
Dennis Rentzeperis,
L. Edward Clemens,
Yi Mu,
Brian E. Lavan
Publication year - 2009
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jcem.94.6.9995
Subject(s) - transactivation , peroxisome proliferator activated receptor , peroxisome , chemistry , receptor , ligand (biochemistry) , medicine , pharmacology , biophysics , microbiology and biotechnology , biochemistry , biology , transcription factor , gene

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom